Peritoneal surface malignancies comprise a heterogeneous group of primary tumours,
including peritoneal mesothelioma, and peritoneal metastases of other tumours, including …

Pseudomyxoma Peritonei (PMP) is a rare peritoneal malignancy, most commonly originating
from a perforated epithelial tumour of the appendix. Given its rarity, randomized controlled …

Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis,
treatment and follow-up - ScienceDirect Skip to main contentSkip to article Elsevier logo …

Introduction The PRODIGE 7-trial investigated the additional value of Hyperthermic
Intraperitoneal Chemotherapy (HIPEC) to cytoreductive surgery (CRS) for patients with …

Background A group of experts from the Peritoneal Surface Oncology Group International
(PSOGI) and the BIG-RENAPE group carried out a consensus among surgeons experienced …

Abstract Background and Aim We report the results of an international consensus on
hyperthermic intraperitoneal chemotherapy (HIPEC) regimens for epithelial ovarian cancer …

Background Selected patients with peritoneal metastases of colorectal cancer (PM-CRC)
can benefit from potentially curative cytoreductive surgery (CRS)±hyperthermic …

Background Diffuse malignant peritoneal mesothelioma (DMPM) is a rare and aggressive
primary peritoneal disease, with recommended treatment, in eligible patients, of a …

Introduction This document is a summary of the French Intergroup guidelines regarding the
management of appendicular epithelial tumors (AT) and pseudomyxoma peritonei (PMP) …

This manuscript reports the results of an international consensus on technologies of
hyperthermic intraperitoneal perioperative chemotherapy (HIPEC) performed with the …